Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05028816 · ClinicalTrials.gov registry record · NA

Force Modulating Tissue Bridges for Closure of Vertical Scars in Breast Reduction

A NA study of Surgical Incision, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
39
Enrollment target
1
Study location

NCT05028816 is a NA study of Surgical Incision that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 39 participants, below the 150-participant average among 3 other Surgical Incision trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05028816, a NA study of Surgical Incision, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target
1
Study location

Study Summary

This is a prospective, within-subject randomized, single blinded study designed to follow up to forty-two (42) qualified and consenting adult females, 18-65 years of age scheduled for elective breast reduction surgery using a standard inverted Wise (inverted "T") incision pattern

Conditions Studied

Interventions

  • DEVICE Side 1: Final layer closure with force modulating tissue bridges (FMTB)
  • OTHER Side 1: Final layer dermal closure with poliglecaprone 25 suture
  • DEVICE Side 2: Final layer closure with force modulating tissue bridges (FMTB)
  • OTHER Side 2: Final layer dermal closure with poliglecaprone 25 suture

Study Locations (1)

Texas

  • UT Southwestern Medical Center- Outpatient Building - Dallas

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2021-10-05
Est. Completion 2024-12-01
Phase NA

What the Registry Record Tells You About NCT05028816

The ClinicalTrials.gov registry entry for NCT05028816 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 150-participant average among 3 other Surgical Incision trials with a reported enrollment target (74% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Surgical Incision appearing as the primary indexed condition, and to 4 interventions - of which Side 1: Final layer closure with force modulating tissue bridges (FMTB) is the first listed.

NCT05028816 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05028816 about?

NCT05028816 is a clinical study titled "Force Modulating Tissue Bridges for Closure of Vertical Scars in Breast Reduction". This is a prospective, within-subject randomized, single blinded study designed to follow up to forty-two (42) qualified and consenting adult females, 18-65 years of age scheduled for elective breast reduction surgery using a standard inverted Wise (inverted "T") incision pattern

What is the current status of trial NCT05028816?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2021-10-05. Estimated completion is 2024-12-01.

What conditions does trial NCT05028816 study?

This clinical trial studies the following conditions: Surgical Incision.

What interventions are being tested in trial NCT05028816?

The interventions under investigation include: Side 1: Final layer closure with force modulating tissue bridges (FMTB) (DEVICE), Side 1: Final layer dermal closure with poliglecaprone 25 suture (OTHER), Side 2: Final layer closure with force modulating tissue bridges (FMTB) (DEVICE), Side 2: Final layer dermal closure with poliglecaprone 25 suture (OTHER).

Who is sponsoring clinical trial NCT05028816?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05028816 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Incision

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.